UBS Group’s AllianzIM U.S. Equity Buffer20 Mar ETF MARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-143
Closed -$4.91K 10893
2025
Q4
$4.91K Buy
+143
New +$4.84K ﹤0.01% 8763
2025
Q3
Sell
-12
Closed -$390 10679
2025
Q2
$390 Buy
+12
New +$376 ﹤0.01% 9840
2025
Q1
Sell
-2,138
Closed -$66.4K 10521
2024
Q4
$66.4K Buy
+2,138
New +$65.9K ﹤0.01% 7121
2024
Q3
Sell
-547
Closed -$16.1K 9842
2024
Q2
$16.1K Buy
+547
New +$15.8K ﹤0.01% 7443
2024
Q1
Sell
-670
Closed -$18.7K 9746
2023
Q4
$18.7K Buy
670
+570
+570% +$15.5K ﹤0.01% 7148
2023
Q3
$2.65K Buy
+100
New +$2.67K ﹤0.01% 7668

Other funds holding MARW

UBS Group's MARW Position: Q1 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity Buffer20 Mar ETF (MARW) in Q1 2026, closing a stake of 143 shares — an estimated $4.91K sold.

UBS Group first reported a position in MARW in Q3 2023 and held it in 6 quarters. The position peaked at $66.4K in Q4 2024. 41 funds tracked by Wall St. Rank hold MARW as of Q1 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity Buffer20 Mar ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 143 AllianzIM U.S. Equity Buffer20 Mar ETF shares in Q1 2026, an estimated $4.91K.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer20 Mar ETF in Q3 2023 and held it in 6 quarters.
  • UBS Group's AllianzIM U.S. Equity Buffer20 Mar ETF position peaked at $66.4K in Q4 2024.
  • 41 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Mar ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.